Accéder au contenu
Merck
  • Design, synthesis, and discovery of stilbene derivatives based on lithospermic acid B as potent protein tyrosine phosphatase 1B inhibitors.

Design, synthesis, and discovery of stilbene derivatives based on lithospermic acid B as potent protein tyrosine phosphatase 1B inhibitors.

Bioorganic & medicinal chemistry letters (2007-06-29)
Mankil Jung, Yongnam Lee, Moonsoo Park, Hanjo Kim, Heekyeong Kim, Eunyoung Lim, Jungae Tak, Minjoo Sim, Dongeun Lee, Namsoo Park, Won Keun Oh, Kyu Yeon Hur, Eun Seok Kang, Hyun-Chul Lee
RÉSUMÉ

Dihydroxy stilbene derivatives were designed based on lithospermic acid B and were prepared from 4-(chloromethyl)benzoic acid. The inhibitory activities of the novel compounds against protein tyrosine phosphatase 1B (PTP1B) were evaluated. 3,4-Dihydroxy stilbene carbonyl compounds (7, 11b, 27b) inhibited PTP1B with IC50 values comparable to molybdate, while the conjugation-extended compound (15b) showed inhibition 3-fold better than preclinical RK682. The introduction of electron withdrawing groups or amides into the second phenyl ring, or extension of the conjugation into the stilbene molecule may increase stability of the generated radicals.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Caffeic acid, ≥98.0% (HPLC)
Sigma-Aldrich
cis-Stilbene, 96%
Sigma-Aldrich
4-(Chloromethyl)benzoic acid, 95%
Sigma-Aldrich
Salvianolic acid B, ≥94% (HPLC)
Supelco
Caffeic acid, matrix substance for MALDI-MS, ≥99.0% (HPLC)
Supelco
Salvianolic acid B, analytical standard